Market Minds Advisory
Bedless Hospitals Market

Bedless Hospitals Market: Hospital-at-Home Platform and Mobile Care Dynamics

Hospital capacity constraints and regulatory waivers permitting acute-level home care are pulling inpatient treatment out of physical wards, forcing health systems to buy monitoring platforms and mobile nursing capability instead of more beds.

Lead Analyst

Alice Ballenger

Published

September 2026

Make Smarter Decisions with Customized Research Insights

Request a free sample report and evaluate market opportunities, growth trends, and competitive dynamics relevant to your business needs.

2025 MARKET VALUE$3.2BMarket Size 2025
2036 FORECAST VALUE$16.7BBase Case , 2026 to 2036
CAGR 2026 TO 203616.2 %Bull 17.4% / Bear 14.9%
INCREMENTAL OPPORTUNITY$13.0BNet 10- year value creation
EXPANSION MULTIPLE4.48x2036 value over 2026 base
Strategic Levers
M&A Pipeline
Regional Outlook
Country Rankings
Competitive Intelligence
Segmental Deep-dive
Call-Us : 91 93563 13602

Executive Snapshot and Market Trajectory

Bedless hospital programs are moving acute-level care out of physical wards entirely as regulatory waivers and hospital capacity constraints push health systems toward home-based delivery models that require monitoring platforms and mobile nursing rather than additional inpatient beds worldwide each year. Buyers face a narrow field of qualified partners.
Mobile nursing and paramedicine service networks form the fastest-growing segment as health systems discover that monitoring technology alone cannot deliver acute care without reliable in-home clinical staffing to handle escalations and hands-on intervention. North America anchors the deepest commercial concentration, reflecting the regulatory foundation created by federal waivers permitting acute-level home care, alongside established hospital system partnerships that developing decentralized care markets still cannot fully replicate. especially at leading United States academic health system networks.
Medically Home and Best Buy Health set the commercial benchmark through broad hospital system partnership networks and deep consumer device distribution reach respectively, while a fragmented tail of smaller specialty platforms competes on price and regional health system relationships. Expanding hospital capacity pressure and regulatory waiver permanence are both reshaping which companies capture program volume, particularly across smaller regional platforms with fewer resources. Larger firms are hiring to close the gap.
Market Definition
The bedless hospitals market covers technology platforms and services that enable acute-level hospital care to be delivered in a patient's home rather than a physical inpatient ward, including remote patient monitoring devices, program management software, mobile nursing and paramedicine networks, virtual physician consultation platforms, and connected diagnostic testing kits. It spans both the technology infrastructure and clinical service delivery components of hospital-at-home programs operated by health systems and specialized platform companies. General telehealth for non-acute outpatient visits and unrelated remote monitoring for chronic disease management outside acute episodes are excluded from this scope.
Base Year Value
$3.2B in 2025 (MMA Primary Research Dataset, August 2026)
Forecast Period
2026 to 2036, eleven discrete annual values
CAGR
16.2% base case. Bull 17.4%. Bear 14.9%.
Fastest Growth Segment
Mobile Nursing and Paramedicine Service Networks: 20.4% CAGR
Fastest Growth Country
India: 18.6% CAGR
Fastest Growth Region
South Asia and Pacific: 18.2% CAGR
Largest Region
North America: 37% of 2025 global value
Market Leaders
Medically Home, Best Buy Health, DispatchHealth, Contessa Health, Biofourmis. Source: MMA Analysis based on company annual reports.
Primary Survey
n=3,800 procurement and R&D decision-makers, Q4 2025, six countries
Methodology
Demand-side build-up, cross-validated against public data, 47 expert interviews

Bedless Hospitals Market Forecast Scenarios

bedless-hospitals-market-size-forecast-scenario-1787305041756
Bedless hospital program demand grew rapidly across 2020 to 2025 as pandemic-era hospital capacity constraints and regulatory waivers created the operating conditions for acute-level home care, then continued expanding as several health systems demonstrated favorable clinical and cost outcomes. The market grew at an estimated 14.7% historical CAGR across the period, reflecting a genuine step change once regulatory waivers made billing for acute home care commercially viable.
The base case assumes regulatory waivers permitting acute-level home care become permanent policy in major markets through 2030, mobile nursing network capacity expands to meet growing program enrollment, and health systems increasingly treat hospital-at-home infrastructure as a permanent capacity strategy rather than a temporary pandemic response. Together these three mechanisms support a 16.2% forecast CAGR, with remote monitoring platforms remaining the volume anchor even as mobile nursing services capture a growing value share each year worldwide.
The bull case centers on faster-than-expected permanent regulatory policy adoption that removes waiver uncertainty well ahead of current legislative timelines. The bear case centers on regulatory waiver expiration without permanent replacement policy, which would strand health system program investment and slow enrollment growth across cost-constrained health systems for several years across the industry nationwide. each year.

Regulatory Foundation and Staffing Capacity Dynamics

Bedless hospitals sit at the intersection of digital health technology and acute clinical service delivery, since remote monitoring platforms alone cannot substitute for hands-on nursing intervention while pure staffing models without connected monitoring cannot scale cost-effectively across a health system's full eligible patient population. That split has kept the vendor base divided between technology platform companies competing on monitoring sophistication and staffing network operators com
TOP 5 CONCENTRATION38%share held by leading five bedless hospital platform companies
AVERAGE PROGRAM COST$2,200 per episodetypical technology and service cost per acute home care episode
LEADING COUNTRY SHAREUnited States, 31%share of global bedless hospital program enrollment volume overall
HOSPITAL PARTICIPATION RATE18% of eligible hospitalsshare of eligible hospitals operating an active home care program
READMISSION RATE REDUCTION15 to 20% versus inpatienttypical readmission rate reduction relative to comparable inpatient care
MOBILE NURSING COVERAGE58% of enrolled patientsshare of enrolled patients within active mobile nursing service radius
Commercially, the market splits between a mature monitoring technology base sold through established health system procurement channels, and a smaller but rapidly growing mobile nursing tier sold on service network density and clinical outcomes rather than technology features alone. Virtual physician consultation and connected diagnostics round out demand with program-specific purchasing tied to each health system's acuity mix.
Over the next decade, mobile clinical staffing density and regulatory policy certainty will matter more than raw monitoring technology sophistication alone, since health systems increasingly select program partners based on demonstrated service reliability across a defined geographic radius rather than device feature comparisons. Companies that expand mobile nursing capacity into mid-tier regional systems fastest stand to capture a widening share of the market.
"Everyone thought this would be won on monitoring technology. It's actually being won by whoever can reliably get a nurse to someone's door within an hour."
Director, Decentralized Care Delivery Practice · MMA Healthcare / Decentralized

Market Trends

Mobile Nursing Networks Become The Real Bottleneck

Health systems launching bedless hospital programs are discovering that mobile nursing and paramedicine staffing capacity, not monitoring technology, represents the primary constraint limiting how many patients a program can safely enroll within a given geographic service area. Medically Home and DispatchHealth have both expanded mobile clinical staffing networks since 2023 to address this bottleneck, targeting health systems that want reliable in-home escalation response capability matching hospital-level acuity requirements. Technology-only platform providers are adapting more slowly to this staffing reality, but service network expansion is broadening steadily each year across major metropolitan health system markets worldwide.
Market Impact: Adds 8 million eligible patients gl

Health Systems Treat Programs As Permanent Infrastructure

Health systems are increasingly budgeting for bedless hospital programs as permanent capacity infrastructure rather than temporary pandemic-era arrangements, reflecting growing confidence that regulatory waivers will convert into permanent policy and that demonstrated clinical outcomes justify sustained investment regardless of near-term policy uncertainty. Best Buy Health and Contessa Health have both expanded long-term health system partnership agreements since 2023, targeting systems that want multi-year program commitments rather than pilot-scale arrangements. This permanence shift is letting health systems make longer-term capital planning decisions around home-based capacity. Health systems increasingly view this permanence as a meaningful signal worth incorporating into long-term budgeting.
Market Impact: Expands coverage by 22 million live

Market Opportunities and Growth Drivers

Hospital Bed Capacity Constraints Sustain Long-Term Demand

Hospital bed capacity constraints continue affecting health systems across major markets each year, with aging populations and rising chronic disease prevalence expanding acute care demand faster than most health systems can economically add physical inpatient bed capacity through traditional facility construction. This capacity constraint sustains long-term demand for bedless hospital alternatives regardless of near-term regulatory policy cycles in any single market, providing a durable baseline growth floor beneath the faster-growing mobile nursing capacity expansion layered on top of it. Health systems increasingly view home-based capacity as more capital-efficient than new facility construction.
Market Impact: Threatens 100% of current enrollmen

Demonstrated Cost And Outcomes Data Expand Payer Support

Growing clinical outcomes data demonstrating comparable or improved patient outcomes at meaningfully lower cost than traditional inpatient care is expanding payer willingness to reimburse bedless hospital programs beyond the initial pandemic-era emergency waiver framework. Several major insurers have expanded coverage policy since 2023 as published outcomes data accumulates across multiple health system programs, reducing the reimbursement uncertainty that previously constrained broader program expansion. Programs with strong published outcomes data are capturing disproportionate payer coverage support as this evidence base continues growing. Companies with strong published evidence increasingly capture this expanding coverage-driven volume first.
Market Impact: Limits expansion to 58% of areas

Market Restraints and Challenges

Regulatory Waiver Uncertainty Constrains Long-Term Investment

Regulatory waivers permitting acute-level home care billing remain subject to periodic legislative renewal in several major markets, creating investment uncertainty for health systems and platform companies evaluating whether to commit substantial capital to program infrastructure that could lose its reimbursement foundation without advance warning. This constraint is most severe for health systems considering major mobile nursing network buildout, since staffing infrastructure represents a multi-year commitment that waiver expiration could strand entirely. Companies and health systems are jointly advocating for permanent legislative policy to replace the current waiver framework, though achieving permanent policy certainty will likely take considerable additional legislative engagement.
Market Impact: Adds $2,200 per home care episode

Mobile Nursing Staffing Shortages Limit Program Expansion

Mobile nursing and paramedicine staffing shortages limit how quickly bedless hospital programs can expand enrollment, since the specialized clinical skills required for home-based acute care management remain scarce relative to growing program demand across an increasingly competitive healthcare labor market. This constraint is particularly acute in markets where competing healthcare employers offer more predictable scheduling and lower travel burden than mobile home care roles require. Companies are responding by expanding training pipelines and offering premium compensation to attract qualified mobile nursing staff, though closing this staffing gap meaningfully will take considerable additional time.
Market Impact: Cuts inpatient bed demand by 12%
3 additional market trends, 2 additional growth drivers, and 3 additional restraints and challenges are covered in the full report. Contact sales@marketmindsadvisory.com to access the complete intelligence.

Segment CAGR and Growth Architecture

Bedless hospital offerings segment by technology and service delivery type, the classification health systems use to set program scope, staffing model, and pricing structure, since monitoring, staffing, and diagnostic buyers each negotiate under distinct operational terms. Vendors price each category differently depending on clinical service intensity and technology sophistication involved. Health systems weigh both factors closely when selecting a partner.
bedless-hospitals-market-market-share-analysis-1787305042283

Mobile Nursing and Paramedicine Service Networks

Mobile nursing and paramedicine service networks form the fastest-growing segment as health systems discover that reliable in-home clinical staffing, not monitoring technology alone, determines how many patients a bedless hospital program can safely enroll. Medically Home and DispatchHealth have both expanded mobile clinical staffing capacity since 2023, targeting health systems that want dependable escalation response matching hospital-level acuity requirements within defined geographic service areas. Companies that build strong regional staffing networks early are capturing program volume from health systems that lack access to comparable mobile clinical capability, an advantage that compounds as more systems standardize around proven staffing partners. If staffing capacity expansion continues, this segment could approach a meaningful share of total category value.
CAGR 20.4%

Connected Diagnostic and Point-of-Care Testing Kits

Connected diagnostic and point-of-care testing kits form the second-fastest segment as bedless hospital programs increasingly require in-home laboratory and imaging capability that matches what inpatient wards can provide for accurate acute condition monitoring. Philips Healthcare and Masimo have both expanded portable diagnostic device offerings since 2023, targeting programs that want comprehensive point-of-care testing without requiring patient transport to a physical facility. Programs that adopt comprehensive diagnostic capability early are capturing enrollment volume from systems limited to basic vital sign monitoring alone, an advantage that compounds as clinical protocols expand to cover more complex acute conditions. This segment increasingly determines which acuity levels a program can safely manage at home. Payers increasingly view this as a durable differentiator.
CAGR 17.6%
Full segment breakdown across 6 segments available in the complete report.

Regional Architecture and Country Demand Map

Bedless hospital commercial activity concentrates where regulatory waiver frameworks and health system partnership infrastructure are most established, even though hospital capacity pressure driving underlying demand is distributed globally rather than concentrated in any particular region worldwide each year. particularly across major metropolitan health system clusters worldwide.

North America

The United States accounts for the overwhelming majority of North America's bedless hospital commercial value, reflecting the Centers for Medicare and Medicaid Services waiver that created the specific regulatory and reimbursement foundation permitting acute-level home care billing, alongside dense health system partnership networks and platform company headquarters presence, which is why this region sits above MMA's standard regional share band for this market. Canada contributes a smaller but growing share as provincial health systems evaluate similar home-based acute care models following United States regulatory precedent. Mobile nursing network density runs meaningfully ahead of the global average across most large metropolitan health systems in the region. Program enrollment continues expanding steadily each year as more hospitals launch formal bedless programs.
Share: 37% | CAGR: 17.0% (2026 to 2036)

Western Europe

The United Kingdom, Germany, and France together anchor Western Europe's bedless hospital demand, reflecting the National Health Service's established hospital-at-home program history and comparatively strong national health system infrastructure supporting home-based acute care delivery. Regulatory frameworks across the region vary meaningfully by country, with some national health systems moving more cautiously on program expansion than the more centralized United States Medicare waiver approach allows. Smaller Western European markets rely more heavily on regional health authority pilot programs rather than nationally coordinated rollout, concentrating program volume at fewer high-visibility demonstration sites. Regional mobile nursing capacity continues expanding as programs demonstrate favorable outcomes data. Regional health authorities increasingly evaluate outcomes data before broader program expansion.
Share: 21% | CAGR: 14.9% (2026 to 2036)
Regional intelligence for 5 additional markets available in the complete report: East Asia, South Asia and Pacific, Latin America, Middle East and Africa, Eastern Europe. Contact sales@marketmindsadvisory.com.
bedless-hospitals-market-country-cagr-analysis-1787305042801

Where Program Value Concentrates Next

Revenue growth in bedless hospitals increasingly depends on capturing mobile nursing network expansion, permanent regulatory policy positioning, and comprehensive diagnostic capability rather than raw monitoring device volume alone, since clinical staffing reliability, not raw technology sophistication, is reshaping where program value concentrates. The levers below outline where that value is concentrating fastest across the care delivery pathway today.

Expanding Mobile Nursing Network Capacity Further

Companies expanding mobile nursing network capacity are capturing health system partnerships that staffing-constrained competitors cannot fulfill, particularly as more systems face approaching enrollment demand that existing clinical staffing cannot support. Building competitive mobile nursing capacity typically costs $12 million to $28 million in recruitment, training, and regional infrastructure investment. Companies without adequate staffing capacity increasingly lose health system relationships to better-positioned competitors offering reliable service coverage sooner. Companies without such investment risk losing health system relationships to better-positioned competitors permanently over time. That advantage compounds further as more health systems standardize around reliable staffing partners.
Market Impact: Costs $12 to $28 million to fully b

Building Much Broader Regulatory Policy Advocacy

Companies building regulatory policy advocacy partnerships with health system associations and legislative stakeholders are capturing long-term investment confidence that remains uncertain absent permanent policy replacement for the current waiver framework. Building competitive advocacy infrastructure typically costs $3 million to $8 million in policy engagement, outcomes data generation, and stakeholder relationship investment. Companies with strong regulatory positioning increasingly win health system trust from systems still cautious about waiver-dependent program investment. Companies without such positioning risk missing this policy certainty wave as competitors secure favorable legislative outcomes first. That advantage compounds further as more health systems formalize long-term investment commitments.
Market Impact: Costs $3 to $8 million to fully bui

Securing Much Broader Diagnostic Capability Partnerships

Companies securing partnerships that integrate comprehensive point-of-care diagnostic capability into program offerings are capturing higher-acuity patient enrollment that basic vital-sign-only monitoring cannot safely support. These partnerships typically carry a 15 to 24% margin premium over basic monitoring-only programs given the expanded acuity range and clinical capability comprehensive diagnostics enable. Companies able to demonstrate safe higher-acuity management increasingly win expanded program mandates from health systems seeking broader capacity relief. Companies without such partnerships compete purely on lower-acuity enrollment when higher-acuity capability increasingly matters. That advantage compounds further as more programs expand into higher-acuity patient populations.
Market Impact: Commands a 15 to 24% margin premium

Investing In Published Clinical Outcomes Evidence

Companies investing in published clinical outcomes and cost-effectiveness evidence generation are positioned to capture payer coverage expansion that programs lacking comparable published data cannot access as reimbursement decisions increasingly require demonstrated evidence beyond pandemic-era emergency authorization alone. Building a competitive evidence generation program typically costs $5 million to $12 million in clinical data infrastructure, research partnership, and publication investment over several years. Companies with mature outcomes evidence increasingly win faster payer coverage decisions from insurers still evaluating broader reimbursement policy. Companies without such evidence face slower payer coverage expansion indefinitely.
Market Impact: Costs $5 to $12 million to fully bu

Who Controls the Margin Pool

The top five vendors hold an estimated 38% of global bedless hospital revenue, a fragmented plurality reflecting the wide range of technology and staffing niches spanning both established monitoring platforms and newer mobile clinical service networks. Medically Home and Best Buy Health lead on hospital system partnership scale and consumer device distribution reach respectively, while a fragmented tail of smaller specialty platforms competes on price and regional service relationships.
Current competitive activity centers on three fronts. Mobile nursing network expansion is opening a new front for companies willing to invest ahead of confirmed long-term enrollment growth. Regulatory policy advocacy is becoming increasingly important as companies compete for health system trust amid ongoing waiver uncertainty. And several mid-sized platforms are pursuing comprehensive diagnostic capability partnerships to differentiate beyond basic monitoring-only program offerings.

Emerging pressure comes from regional healthcare staffing companies moving into mobile nursing service delivery as they partner with monitoring technology providers, though matching Medically Home or Best Buy Health's hospital system relationships and scale remains years away for most. If these challengers close that gap, expect share to shift within regional relationships first, before pressure reaches the largest incumbents.
bedless-hospitals-market-company-positioning-matrix-1787305043325

Competitive Moat and Risk Dimensions

MEDICALLY HOME GROUP INC.

Moat: Broadest Hospital System Partnership Network

Medically Home operates one of the industry's broadest hospital system partnership networks, built through years of continuous relationship development across major health systems seeking comprehensive program management support. That partnership breadth gives Medically Home a durable relationship advantage that narrower competitors cannot quickly replicate, even as mobile nursing capacity demand continues attracting new entrants into the category.
MEDICALLY HOME GROUP INC.

Risk: Depends On Hospital Capital Budgets

Medically Home's growth depends substantially on health system willingness to commit capital budget toward program infrastructure, creating exposure to broader hospital capital spending cycles that could tighten during periods of health system financial pressure. If hospital margins compress meaningfully, Medically Home risks slower program expansion despite strong underlying demand for capacity relief.
BEST BUY HEALTH INC.

Moat: Deep Consumer Device Distribution Reach

Best Buy Health uses its parent company's extensive consumer retail and logistics infrastructure to distribute monitoring devices and technical support at a scale that specialized healthcare-only competitors cannot easily match. That distribution reach gives Best Buy Health a durable cost and logistics advantage for the device deployment component of bedless hospital programs.
BEST BUY HEALTH INC.

Risk: Limited Clinical Services Capability

Best Buy Health's core strength in device distribution and consumer technical support does not extend to the mobile nursing and clinical staffing capability that health systems increasingly recognize as the primary program bottleneck. If clinical service delivery continues determining competitive outcomes more than device distribution, Best Buy Health risks losing share to more clinically integrated competitors.

Players Tracked

Prominent Players

Medically Home Group Inc.
Best Buy Health Inc.
DispatchHealth Management LLC
Contessa Health
Biofourmis Inc.

Other Key Players

Huma Therapeutics Ltd.
Cadence Health Inc.
Included Health Inc.
Ready Responders Inc.
Homeward Health Inc.
Inbound Health Inc.
Philips Healthcare
Masimo Corporation
GE HealthCare Technologies Inc.
Vivify Health Inc.
Teladoc Health Inc.
American Well Corporation
Current Health Ltd.
CareCentrix Inc.
Reemo Health Inc.

Recent Developments

APRIL 2025

Medically Home Expands Mobile Nursing Network Capacity

Medically Home commissioned additional mobile nursing network capacity across several major metropolitan markets to meet rising health system demand for reliable acute-level home care staffing, following sustained partner demand that had pushed existing capacity toward its operating limits. The expansion followed multi-year health system commitments signed ahead of staffing buildout.
Signal: Confirms mobile staffing capacity remains
OCTOBER 2024

Best Buy Health Signs Multi-Year Health System Agreement

Best Buy Health secured a multi-year technology deployment agreement with a major regional health system network, guaranteeing device installation and technical support through 2029 across several affiliated bedless hospital programs. The agreement reflects health systems' push to lock in reliable technology partnerships. Similar agreements are expected across other qualified competitors.
Signal: Shows health systems prioritizing long-ter
JANUARY 2025

Biofourmis Announces Expanded Outcomes Data Publication

Biofourmis announced publication of expanded multi-year clinical outcomes data demonstrating comparable safety and improved cost efficiency for its bedless hospital program relative to traditional inpatient care, adding to the growing evidence base supporting broader payer coverage. Similar publications are expected across other qualified competitors soon.
Signal: Signals published outcomes evidence is acc

Clinical Staffing and Device Hardware Cost Pressure

Mobile nursing labor and clinical staffing costs together account for roughly 46% of effective cost of goods for bedless hospital program operators, given the specialized skills and premium compensation required to attract qualified home-based acute care clinical staff. Remote monitoring device hardware and connectivity infrastructure costs add a further meaningful share, particularly for programs supporting comprehensive diagnostic capability.
Clinical staffing costs rose meaningfully following 2022 broader healthcare labor market tightening, with several companies reporting labor cost increases exceeding 23% in their annual reports before pricing stabilized through 2023 and into 2024. Industry supply chain reviews have flagged clinical staffing availability as this market's single most concentrated cost driver, more than device hardware or connectivity costs combined. Several companies have flagged staffing cost pressure as an ongoing operational risk.

Smaller regional platforms without established staffing pipelines absorbed the 2022 cost increases hardest, losing health system contract bids to larger competitors including Medically Home and DispatchHealth that had built dedicated recruitment and training infrastructure years in advance. Companies with secured staffing pipelines weathered the cost increases far better than those dependent on spot market contract staffing, a cost advantage that persists most sharply across smaller regional platforms today.
bedless-hospitals-market-cost-volatility-analysis-1787305043520

Dedicated Training Pipelines Secure Staffing Availability

Companies increasingly build dedicated clinical training and recruitment pipelines partnering with nursing schools and paramedicine programs, reducing exposure to spot market staffing cost volatility during periods of broader healthcare labor market tightening. This approach has helped several companies maintain more stable program pricing even during periods of broader labor cost inflation across the industry.

Shared Regional Staffing Infrastructure Lowers Fixed Cost

Smaller regional platforms increasingly share mobile nursing staffing infrastructure through partnership arrangements, spreading fixed recruitment and training cost across broader service volume than any single smaller operation could support alone economically. This shared infrastructure model has helped smaller players remain price-competitive against larger integrated companies. This model is becoming common as smaller platforms scale without heavy capital investment.

Remote Monitoring Efficiency Reduces Staffing Intensity

Several larger companies are investing in more sophisticated remote monitoring algorithms that reduce unnecessary in-person nursing visits by better predicting which patients genuinely require hands-on intervention, gaining staffing efficiency that less sophisticated competitors cannot match. This efficiency also reduces exposure to acute staffing shortages during periods of tightening labor availability. This has helped several companies weather recent volatility.

Portfolio Architecture for Margin Defence

Bedless hospital portfolios span three margin tiers, from commodity-adjacent basic remote monitoring device sales sold largely on price, through certified program management and staffing services carrying service-intensity-driven premiums, toward an emerging next-generation tier built around comprehensive diagnostic and outcomes-evidence-backed programs still gaining share. Gross margin widens meaningfully at each tier as clinical service intensity and evidence depth increase across the industry
The volume versus premium tension centers on staffing and evidence investment allocation. Companies must choose between dedicating capital to high-margin comprehensive diagnostic and outcomes-evidence programs with growing but still-smaller volume, or serving reliable basic monitoring demand that fills out most device volume across a typical year. Companies without spare capital increasingly favor higher-margin next-generation programs where competition remains comparatively thin still.

High-value margin pools concentrate in comprehensive diagnostic capability and outcomes-evidence-backed programs, where staffing investment and clinical evidence depth keep competition thin and health systems pay a premium for demonstrated reliability and expanded acuity coverage. Basic monitoring device sales remain the volume anchor but carry the thinnest margins across the entire portfolio, leaving smaller companies with fewer diversification options than larger integrated competitors today.

Volume / Commodity-Adjacent Tier

Basic remote monitoring device sales sold largely on price and distributor availability without service-intensity-driven premiums, across most standard health system buyer segments worldwide each year. Pricing pressure from health system purchasing committees keeps margins comparatively thin across this tier.
Gross Margin: 18-28%

Premium / Certified Tier

Program management and mobile nursing staffing services sold under health system contracts carrying service-intensity-driven pricing power built through years of proven program performance across major systems worldwide. Health systems increasingly compare service reliability data before committing to a long-term relationship.
Gross Margin: 32-44%

Sustainability / Regulatory / Next-Generation Tier

Comprehensive diagnostic and outcomes-evidence-backed programs in active health system adoption, commanding premium pricing against limited proven alternatives as clinical capability and evidence expand across major markets. Companies with the deepest evidence and diagnostic capability capture most of this premium value.
Gross Margin: 44-56%
bedless-hospitals-market-portfolio-architecture-1787305044016

Recurring Health System Program Relationships

Bedless hospital purchasing functions closer to a recurring annuity than a single transaction, since health systems that launch a formal program typically continue operating it across many subsequent patient episodes for the life of the technology and staffing partnership contract rather than treating each episode as a standalone purchase decision. Individual patient enrollment behaves differently, tracking acute care episode incidence rather than any recurring subscription pattern.
Adoption depth varies sharply by end-use vertical. Large academic health systems and integrated delivery networks show the deepest engagement with comprehensive program infrastructure, given dedicated capital budgets and organizational capacity to manage complex mobile staffing logistics, while smaller community hospitals adopt more slowly since program investment rarely gets justified by comparatively low individual patient volume. That divide shapes where companies concentrate commercial and staffing infrastructure investment.

A generational shift is underway as younger hospital administrators, trained during the era of routine home-based acute care availability, evaluate capacity strategy on program partnership depth and staffing reliability rather than decades-long assumptions that inpatient beds represent the only viable acute care delivery model. That openness gives service-forward companies a rare opening to win share in a category where legacy facility-centric thinking has otherwise been difficult to dislodge.
bedless-hospitals-market-end-use-penetration-index-1787305044501

Where MMA Sees The Opportunity

These are among the four positions where our research anticipates prominent divergence between winners and laggards over the coming forecast period. Each is grounded in the demand model, the regulatory perimeter, and the announced capacity pipeline.
01 / MOBILE STAFFING INVESTMENT

Expand Mobile Nursing Capacity Before Enrollment Demand Peaks

Health systems are increasingly requiring reliable mobile staffing capacity before adopting a company as their primary program partner, and companies without adequate staffing investment are losing health system relationships to better-equipped competitors as this shift accelerates. Staffing investment requires meaningful upfront capital but opens durable health system relationships that staffing-constrained competitors cannot match once enrollment demand fully materializes. Companies waiting until demand fully peaks will find themselves racing to catch up against incumbents who invested years earlier, a gap that widens with each passing quarter of delay.
02 / REGULATORY POLICY POSITIONING

Build Policy Advocacy Before Waiver Uncertainty Resolves

Health systems have not universally committed to major program investment absent permanent regulatory policy certainty, leaving a genuine opportunity for companies willing to fund advocacy ahead of confirmed legislative resolution timelines. Waiting for policy certainty to fully resolve organically risks missing the investment confidence window entirely once health systems broadly commit capital budgets. The investment required is meaningful but positions early movers to capture a category growing faster than facility-based care today, a window that will not stay open indefinitely.
03 / DIAGNOSTIC CAPABILITY EXPANSION

Pursue Comprehensive Diagnostics Before Acuity Standards Rise

Health systems have repeatedly favored programs with broader acuity coverage first, and companies without dedicated comprehensive diagnostic investment risk ceding this growing higher-acuity segment to competitors who invest in capability earlier. Diagnostic expansion represents a meaningful differentiation opportunity even though basic monitoring currently drives most category revenue. Companies pursuing diagnostic investment now, while competitive density remains manageable, protect program mandates against the next wave of competitors entering this category as acuity standards continue rising across most major health system markets.
04 / REGIONAL ACCESS INVESTMENT

Prioritize South Asia and East Asia Access Investment Now

South Asia and Pacific and East Asia carry severe hospital bed capacity constraints relative to their current commercial bedless hospital value, as digital health infrastructure investment accelerates across India, China, and neighboring markets. Companies concentrating capacity expansion solely around legacy North American health system relationships risk ceding share in the regions where program demand growth will be steepest through 2036. Early investment in regional staffing and technology partnerships offers a meaningful head start over competitors still anchored entirely to legacy Western customer bases.

Engagement Snapshot From the Field

A live engagement with an industry participant carrying material or product regulatory and market exposure ahead of a defining policy shift, showing how our research translates into a defensible multi-year portfolio strategy.
MARKET MINDS ADVISORY · CLIENT ENGAGEMENT SUMMARY
Bedless Hospitals Producer Strategic Portfolio Review and Transition Roadmap 2026·Investment Scenario on Bedless Hospitals Exposure Evaluation 2025-26
CLIENT PROFILE
The client is a large regional health system network operating multiple hospitals across a major United States metropolitan area, managing substantial inpatient capacity constraints during peak seasonal demand periods. The network reported annual patient services revenue of approximately $2.1 billion (client-reported, unverified by MMA) and was evaluating whether to launch a formal bedless hospital program or continue relying on traditional capacity management approaches instead.
STRATEGIC CHALLENGE
Leadership needed to decide whether launching a formal bedless hospital program, which required substantial capital investment in mobile staffing and monitoring infrastructure, would generate sufficient capacity relief and cost savings to justify the investment relative to continuing traditional approaches like temporary staffing surges and diversion protocols. Competing regional health systems were beginning to launch similar programs.
MMA APPROACH
MMA benchmarked the client's capacity constraints against comparable health systems that had already launched bedless hospital programs, modeling capacity relief and cost savings against staffing and technology investment requirements. The analysis incorporated primary survey data from health system administrators at thirteen comparable regional networks. Findings were cross-checked against capacity benchmarks published in recent industry surveys.
KEY FINDINGS
  1. Capacity relief from program launch exceeded management's initial projections once seasonal demand variability was properly incorporated into the operational planning model used for this specific analysis.
  2. Peer health systems that launched programs reported measurably stronger patient satisfaction and readmission outcomes than systems relying entirely on traditional inpatient-only capacity management.
  3. Staffing investment payback occurred faster than initially budgeted once reduced inpatient bed-day costs were properly incorporated into the financial model used for this transition.
  4. Continuing traditional capacity management carried a quantifiable competitive risk as patients and referring physicians increasingly viewed program availability as a marker of overall health system capability.
CLIENT PROFILE
The client is a large regional health system network operating multiple hospitals across a major United States metropolitan area, managing substantial inpatient capacity constraints during peak seasonal demand periods. The network reported annual patient services revenue of approximately $2.1 billion (client-reported, unverified by MMA) and was evaluating whether to launch a formal bedless hospital program or continue relying on traditional capacity management approaches instead.
STRATEGIC CHALLENGE
Leadership needed to decide whether launching a formal bedless hospital program, which required substantial capital investment in mobile staffing and monitoring infrastructure, would generate sufficient capacity relief and cost savings to justify the investment relative to continuing traditional approaches like temporary staffing surges and diversion protocols. Competing regional health systems were beginning to launch similar programs.
MMA APPROACH
MMA benchmarked the client's capacity constraints against comparable health systems that had already launched bedless hospital programs, modeling capacity relief and cost savings against staffing and technology investment requirements. The analysis incorporated primary survey data from health system administrators at thirteen comparable regional networks. Findings were cross-checked against capacity benchmarks published in recent industry surveys.
KEY FINDINGS
  1. Capacity relief from program launch exceeded management's initial projections once seasonal demand variability was properly incorporated into the operational planning model used for this specific analysis.
  2. Peer health systems that launched programs reported measurably stronger patient satisfaction and readmission outcomes than systems relying entirely on traditional inpatient-only capacity management.
  3. Staffing investment payback occurred faster than initially budgeted once reduced inpatient bed-day costs were properly incorporated into the financial model used for this transition.
  4. Continuing traditional capacity management carried a quantifiable competitive risk as patients and referring physicians increasingly viewed program availability as a marker of overall health system capability.
RECOMMENDED STRATEGY
Phase 1: Phase 1 (Months 1 to 6): Recruit mobile nursing staff and establish monitoring technology partnerships ahead of formal program launch across pilot service areas. Phase 2: Phase 2 (Months 7 to 15): Launch the formal bedless hospital program while tracking capacity relief and patient outcomes against the modeled benchmark closely. Phase 3: Phase 3 (Months 16 to 24): Expand program service area and acuity coverage to capture broader capacity relief once initial performance demonstrates sustained operational benefits.
OUTCOME
Within eighteen months of launch, the client reported inpatient capacity relief of approximately 11% during peak demand periods (client-reported, unverified by MMA), exceeding initial projections meaningfully. Patient satisfaction scores improved measurably (client-reported, unverified by MMA), and the network now serves as a regional reference model for peer health systems.

Frequently Asked Questions

Foundational context covering the market sizes, CAGR, scope, country, region and competition that inform every finding below. This section is provided to cover basics and most often pre-purchase conversations, answered from the MMA Primary Research Dataset.

What is the current size of the Bedless Hospitals Market?

The global bedless hospitals market was valued at approximately $3.2 billion in 2025. Growth is driven primarily by hospital capacity constraints and expanding regulatory support for acute-level home care.

How large will the Bedless Hospitals Market be by 2036?

The market is forecast to reach approximately $16.68 billion by 2036, roughly 4.48 times its 2026 value as mobile nursing and diagnostic capability broaden globally.

What is the CAGR for the Bedless Hospitals Market 2026 to 2036?

The market is forecast to grow at a 16.2% CAGR between 2026 and 2036. Bull and bear scenarios range from roughly 14.9% to 17.4% depending on regulatory policy and staffing conditions.

Which segment is growing fastest?

Mobile nursing and paramedicine service networks are the fastest-growing segment at approximately 20.4% CAGR, roughly 1.26 times the overall market growth rate. Connected diagnostic testing kits follow as the second-fastest segment.

Who are the major companies in the Bedless Hospitals Market?

Leading companies include Medically Home, Best Buy Health, DispatchHealth, Contessa Health, and Biofourmis, together holding an estimated 38% of global commercial revenue. Smaller regional platforms make up the remaining fragmented share.

Which country is growing fastest?

India is the fastest-growing country at approximately 18.6% CAGR, driven by severe hospital bed shortages and rapidly digitizing healthcare infrastructure. The United States still commands the largest overall share of commercial value.

Report Segmentation Architecture

The full report scope spans multiple orthogonal segmentation dimensions, with cross-tabulated demand data provided for each dimension pair. Coverage extends further to regional breakdowns, trend trajectories, and the competitive detail needed to support segment-level decision-making.

By Technology and Service Delivery Type

  • Remote Patient Monitoring Device Platforms
  • Hospital-at-Home Program Management Software
  • Mobile Nursing and Paramedicine Service Networks
  • Virtual Physician and Specialist Consultation Platforms
  • Connected Diagnostic and Point-of-Care Testing Kits
  • Medication and Supply Home Delivery Logistics Services

By End-Use Health System Type

  • Academic Health Systems and Integrated Delivery Networks
  • Community Hospital Systems
  • Specialty and Post-Acute Care Networks
  • Government and Public Health System Programs

By Commercial Dimension

  • Health System Technology Procurement
  • Mobile Staffing Service Contracts
  • Payer Coverage and Reimbursement Agreements
  • Direct-to-Patient Program Enrollment

By Region

  • North America
  • Western Europe
  • East Asia
  • South Asia and Pacific
  • Latin America
  • Middle East and Africa
  • Eastern Europe

Scope, Methodology, and Coverage

Every figure in this report is reproducible from documented input assumptions. The scope below maps the historical period, the forecast horizon, the segmentation dimensions, and the countries covered, alongside the underlying primary and qualitative methodology.
Historical Period
2020 to 2025
Forecast Period
2026 to 2036
Base Year
2025 (USD billions; MMA Primary Research Dataset, August 2026)
Market Definition
The bedless hospitals market covers technology platforms and services that enable acute-level hospital care to be delivered in a patient's home rather than a physical inpatient ward, including remote patient monitoring devices, program management software, mobile nursing and paramedicine networks, virtual physician consultation platforms, and connected diagnostic testing kits. It spans both the technology infrastructure and clinical service delivery components of hospital-at-home programs operated by health systems and specialized platform companies. General telehealth for non-acute outpatient visits and unrelated remote monitoring for chronic disease management outside acute episodes are excluded from this scope.
Quantitative Units
USD billions (current prices); enrolled patient episode volume in thousands where applicable
Segmentation Dimensions
By Technology and Service Delivery Type; By End-Use Health System Type; By Commercial Dimension; By Region
Regions Covered
North America, Western Europe, East Asia, South Asia and Pacific, Latin America, Middle East and Africa, Eastern Europe
Countries Covered
USA, China, Germany, France, UK, Japan, South Korea, India, Australia, Canada, Brazil, Mexico, Indonesia, Vietnam, Thailand, Malaysia, UAE, Saudi Arabia, South Africa, Nigeria, Turkey, Poland, Netherlands, Italy, Spain, Sweden, Switzerland, Argentina, Colombia, Singapore, and additional markets relevant to this sector
Key Companies Profiled
Medically Home Group Inc., Best Buy Health Inc., DispatchHealth Management LLC, Contessa Health, Biofourmis Inc., Huma Therapeutics Ltd., Cadence Health Inc., Included Health Inc., Ready Responders Inc., Homeward Health Inc., Inbound Health Inc., Philips Healthcare, Masimo Corporation, GE HealthCare Technologies Inc., Vivify Health Inc., Teladoc Health Inc., American Well Corporation, Current Health Ltd., CareCentrix Inc., Reemo Health Inc.
Quantitative Methodology
Primary survey, n=3,800 respondents, Q4 2025, six countries; demand-side model with trade association cross-validation
Qualitative Methodology
47 expert interviews, Q4 2025; applied to validate demand model assumptions, identify emerging dynamics, and assess competitive positioning
Report Format
PDF and XLSX data workbook (Word format preview document)
Publisher
Market Minds Advisory
Report Code
MMA-2026-HLT-186
Published
August 2026
Contact
sales@marketmindsadvisory.com | www.marketmindsadvisory.com

Purchase the full Bedless Hospitals Market Report (2026 to 2036).

This report provides a comprehensive analysis of the global bedless hospitals market, covering monitoring, staffing, and diagnostic segments across all seven MMA-tracked global regions. It includes detailed market sizing and forecasts through 2036, competitive benchmarking of the top twenty vendors across technology platforms and clinical staffing networks, and segment-level analysis of program adoption. The report draws on MMA's primary survey of 3,800 respondents and 47 expert interviews conducted in the fourth quarter of 2025, supplemented by company disclosures and government health agency data. Buyers receive full access to regional data tables, competitive profiles, and strategic recommendations tailored to technology companies, health systems, and healthcare investors worldwide.
Full seven-region market sizing and forecast data
Competitive benchmarking of twenty profiled industry vendors
Segment-level analysis of program adoption trends
Primary survey data from 3,800 global respondents
Expert interview insights from 47 decentralized care specialists
Strategic recommendations for technology companies and health systems

Built For The People Who Decide

From boardroom strategy to bench-side execution, this report is read cover-to-cover by leaders shaping the next decade of their industry, turning demand scenarios, market dynamics and valuation benchmarks into decisions.
CXOs/ Presidents/ VPs/ Managers
M&A and Corporate Development
Strategy Teams and R&D Heads
Procurement and Product Directors
Regulatory and Compliance Leaders
Investor Relations and Equity Analysts